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ABSTRACT
Antascomicin B is a macrolide isolated from a strain of Micromonospora. It possesses structural
similarities to FK506 and rapamycin and exhibits potent binding ability to FKBP12. Recent reports
suggest that small molecule ligands of FKBP12 possess potent neuroprotective and neurodegenerative
properties in mouse models of Parkinson’s disease. Our approach to the C1-21 fragment of antascomicin
B involves an asymmetric amino-Claisen rearrangement originally developed by Tsunoda et al.

35

report

the scalability of the preparation and rearrangement of an allylic amide possessing a silyloxy group at the
terminal position of the alkene. The Tsunoda-Claisen rearrangement uses inexpensive (S)-αmethylbenzylamine as the chiral auxiliary. The allylic amide underwent rearrangement to establish the
C14 and C15 stereocenters in high yield and good diastereoselectivity. We found a surprisingly high
yielding acid mediated lactonization that was employed to cleave the α-methylbenzyl amide. Details of
these studies and further elaboration of the lactone are discussed. We also describe the progress toward
the synthesis of the C1-21 fragment of the natural product.
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I. MODE OF ACTION OF FK506, RAPAMYCIN AND ANTASCOMICINS
A. Background and Significance
FK506 (tacrolimus),

1-3

a natural product of Streptomyces tukubaensis, and rapamycin (sirolimus),

4-6

produced by Streptomyces hygroscopicus, are potent immunosuppressive agents, which have a mode of
action and toxicity profile similar to those of cyclosporine A (CsA), an immunosuppressive cyclic
undecapeptide produced by Tolypocladiuminflatum (Scheme 1). These three natural products have been
used clinically to prevent rejection of transplantation of kidney, heart, liver and bone marrow.

7

1

The biological modes of action of these promising natural products have been extensively investigated
over the past four decades.

7,8

FK506, cyclosporine A (CsA), and rapamycin belong to a family of

macrocyclic immunosuppressants which share the same initial target at the cellular level. Biochemical
and genetic studies have demonstrated all of the above macrocyclic compounds form active complexes
with specific protein conjugates called immunophilins. CsA interacts with a series of cyclophilin proteins
(CyP) that are prevalent in almost all cells. FK506 and rapamycin bind a class of structurally similar
immunophilins named FK506 binding proteins (FKBPs). FKBP12 is the most important one for the
immunosuppressive activity of rapamycin in the FKBP family.

9,10

Initially, scientists proposed that rapamycin and FK506 induced the inhibition of peptidylprolyl cis-transisomerase (PPIase) activity of the immunophilins and that activity resulted in the immunosuppressive
action of these natural products.

11,12

However, further studies made to several synthetic analogs of

rapamycin and FK506 showed the PPIase binding affinity but did not show the immunosuppressive
activity.

13,14

Therefore, this hypothesis was not enough to explain the action mechanism of these

macrocyclic compounds.

It was later discovered that CsA-cyclophilin and FK506-FKBP12 form a ternary complex with calcineurin,
15

a calcium calmodulin-dependent serine-threonine protein phosphatase.

This latter interaction blocks

the calcineurins’ ability to dephosphorylate the cytoplasmic subunit of nuclear factor of activated T cells
(NF-ATC), preventing its translocation to the nucleus, and consequently the transcription of cytokine
genes, in T lymphocytes.

16

Thus, the principal cause that induces the immunosuppressive effects of CsA

and FK506 at the molecular level is attributed to the inhibition of the translocation of NF-ATC. Similarly,
the rapamycin-FKBP12 complex was determined to be the mammalian target of rapamycin (mTOR),
which inhibits the phosphorylation and activation of serine/threonine kinase, specifically P70 S6 kinase, a
17,18

central regulator of translation and cell proliferation.

2

X-ray crystallography studies of both calcineurin and mTOR via the FK506 or rapamycin-FKBP12
complexes has revealed that the strong binding of both FK506 and rapamycin to FKBP12 is through
hydrophobic interactions using the tricarbonyl pipecolyl fragment of their structure.

19,20

The other portion

of the molecule remains accessible to the solvent. Hence, FK506 and rapamycin are described as having
a binding domain for their interaction with FKBP12, and an effector domain for imparting the cellular
response (Scheme 2). Since FK506 and rapamycin possess nearly similar binding domains, it could
explain why they share the same cellular target. Also, the different biological responses could be
attributed to the effector domain regions where FK506 and rapamycin are quite different. To date, these
interactions are considered the main reason for the differing biological activity of these natural products.

3

In addition to the immunosuppressive activities, it has been reported that FK506, rapamycin and its
derivatives display neuroregenerative and neuroprotective activity, while CsA showed only
7

neuroprotective activity. Due to the fact that these substances easily cross the blood brain barrier, they
could be used in the treatment of nerve injuries and neurological diseases. Even though the mode of
action of the neural activity of FKBP has not yet been fully explained, it has been demonstrated that the
neurotrophic properties of FKBP ligands do not depend on calcineurin-mediated effects. Moreover, FKBP
ligands are now considered prominent targets for the development of new drugs for the treatment and
cure of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

21

4

B. Isolation and Biological Properties of Antascomicins
During the pursuit for novel substances that might exhibit similar bioactivity to FK506 and rapamycin, five
22

new macrolides antascomicins A-E were discovered (Scheme 3).

The macrolides were produced in a

fermentation process of a strain of the genus Micromonospora, isolated from the soil sample collected in
China. The structures of these five compounds were elucidated by NMR spectroscopy and X-ray
crystallographic analysis.

22

This novel family of compounds is structurally related to FK506, binds

strongly to FKBP12 in the same range as do FK506 and rapamycin, but interestingly does not show
immunosuppressive activity. It has been discovered that the levels of FKBP12 found in the brain are
nearly 50 times higher than in the immune system,

23

making these FKBP12 ligands promising targets for

24

probing the neurological system roles.

Scheme 3. Structures and FKBP12 binding assay of antascomicin family

The lack of immunosuppressive activity of antascomicin family has taken the attention of the biochemical
community and has become very attractive for the synthetic organic chemist. Up to date, Ley’s group has
reported the first and only total synthesis of antascomicin B.

25

No other complete synthesis of the

antascomicin family has been published. However, the stereoselective synthesis of the fragments C126,27

C21 and C22-C34 of antascomicin A has been reported by Chakraborty’s group;
al. have described the synthesis of the C18-C34 fragment of antascomicin A.

additionally, Fuwa et

28

5

II. TOWARD THE TOTAL SYNTHESIS OF ANTASCOMICIN B: EFFORTS TO CONSTRUCT THE C1C21 FRAGMENT
A. Retrosynthetic Analysis of Antascomicin B
Both the potentially useful biological properties and the structural features of the antascomicin family
stimulated us to initiate the total synthesis of antascomicin B (1) (Scheme 4). This polyketide target has
potent FKBP12 binding ability, contains lactol, lactone, and lactam functionalities, a masked tricarbonyl
moiety and twelve stereogenic centers. Our retrosynthetic plan involves a ring closing metathesis (RCM)
to close the macrocyclic ring. The acyclic triene 2 will be accessed by assembling the C1-C21 and C22C34 fragments via esterification (Scheme 4). In this report we describe the efforts to synthesize the
fragment C1-C21 of the macrolide.

6

B. Initial Strategy to Prepare the C1-C21 Unit
Our initial approach to prepare the C1-C21 fragment 4 of antascomicin B began with the construction of
the C10-C16 carbon framework, which possesses both 1,2-syn (C14-C16) and 1,4-anti (C11-C14)
stereorelationships. Since extensive studies from our group have demonstrated that the Ireland-Claisen
rearrangement of carvone-derived bis-allylic esters such as 6 occurs with good to high
diastereoselectivity,

29,30

we planned to use this methodology to install the C14-C15 stereocenters.

Additionally, the trisubstituted alkene that is formed at C4 and C5 of the pentenoic acid product 7 can
serve as a latent carbonyl group (Scheme 5). Also, both enantiomers of carvone are commercially
available and inexpensive.

7

Therefore, we would expect to obtain bis-allylic ester 10 through axially selective addition of E-propenyl Li
to (R)-(-)-carvone (5) followed by acylation (Scheme 6). Then, Z-selective enolization of the ester,
followed by silylation would provide silyl ketene acetal 11. Rearrangement via the expected chair-like
transition state would form the ketene acetal product 12 with the desired stereocenters, which would be
converted in situ to Weinreb amide 13. Addition of the vinyl Li species derived from iodide 14 will
generate dienone 15. Formation to tosylhydrazone 16 would follow standard protocols.

8

The plan to generate the 1,4-anti (C11-C14) relative configuration was by diastereoselective reduction of
the tosylhydrazone 16 and subsequent allylic diazene rearrangement (ADR) strain controlled to yield the
E-anti-alkene 17 (Scheme 7). Our group lab has found that the isopropylidene alkene can be selective
reduced by using Wilkinson’s catalyst. Thus, it seems highly probable that the hydrogenation of the
disubstituted E-alkenes would occur similarly to give tetraene 18. Methyl ester 19 would be obtained by
exhaustive ozonolysis of the triene and oxidative fragmentation of the intermediate ozonide under basic
conditions. Weinreb amidation followed by regioselective enolization of the methyl ketone would afford
the desire enol silane 20.

9

Several attempts to synthesize bis-allylic ester 10 by addition of propenyl MgBr or propenyl Li to (R)-(-)carvone (5), followed by in situ acylation of the intermediate alkoxide 9 were unsuccessful. We always
recovered some of the starting carvone and traces of the corresponding allylic alcohol. We also tried to
acylate the previously prepared and isolated allylic alcohol 21 (Scheme 8). However, no acylation
product was obtained using typical acylation conditions, and the bis-allylic alcohol was fully recovered. All
the details and reaction conditions of the above mentioned reactions are published in a Master thesis.

31

We considered both the steric hindrance of the tertiary allylic alcohol and the easy deprotonation of the
corresponding glycolate esters by the intermediate alkoxides were likely causing the difficulty in the
acylation. Also, previous studies in our lab demonstrated that acylation of allylic alcohol 22 did not occur.
However, the acylation reaction of propargylic alcohol 24 proceeded in a good yield (Scheme 9).

32

10

Thus, we tried to acylate the less hindered propargylic alcohol 26, but unfortunately, after examining a
variety of conditions, no acylated product was formed (Scheme 10). Instead, most of the starting alcohol
was recovered. Based on those results, we thought that steric interactions between the bulky protecting
group of the acylating reagent and the hindered tertiary alkoxide did not allow for the acylation.
Therefore, we attempted to make the acetate ester of allylic alcohol 21 (Scheme 11), but a complex
mixture was obtained.

11

1

Analyzing the H-NMR data of the complex mixture, we hypothesized that one possible side reaction for
the acetylation of the alcohol 21 is the formation of the pentadienyl cation 29, which could lead to a
number of allylic rearrangement and decomposition products including esters 30 and 31 (Scheme 11).
This type of allylic rearrangements has been previously observed by both the McIntosh

29

and other

33,34

groups.

12

As we mentioned above, another reasonable explanation why we were not be able to acylate either the
allylic or the propargylic alcohol is because the corresponding hindered tertiary alkoxides are basic
enough to deprotonate the acylating reagent, forming a ketene by elimination of the chloride apparently
although no direct evidence for this was observed (Scheme 12).

13

14

nd

C. 2

Generation Approach to Construct the C10-C16 Fragment

Since all of the efforts toward the preparation of the desired bis-allylic ester derived from (R)-carvone (5)
were unsatisfactory, we revised our synthetic route to construct the C10-C16 fragment (Scheme 13).

We reasoned that propionamide 38 could be synthesized by isomerization of the double bond of β,γunsaturated lactone 37 followed by amide-directed hydrogenation. Using Grubb’s catalyst, target
molecule 37 could be formed by RCM of allyl ester 36, which could be obtained from amide 35. Amide 35
is a product of the asymmetric amino-Claisen rearrangement of silyloxy amide 34, which could be formed
from (S)-α-methylbenzylamine (33).

15

D. Installation of the 1,2-syn (C14-C15) Stereorelationship via Amino-Claisen Rearrangement
1. Amino-Claisen Rearrangement of Amide Enolates
35

Studies of the amino-Claisen rearrangement of amide enolates by Tsunoda’s group have demonstrated
that deprotonation of the E- and Z-N-2-butenyl-N-butylpropanamides 39 with LDA at -78 °C in THF
generated the corresponding Z-enolates 40 (Scheme 14). The rearrangement was induced after removal
o

of THF and heating the enolates at 140 C in decane to generate syn- and anti-N-butyl-2,3-dimethyl-4pentenamides 41, respectively.

The excellent diastereoselectivity achieved from allylic amide E-39 is due to both the exclusive formation
of the Z-enolate due to allylic strain

36

and the chair conformation of the transition state of the amino-

Claisen rearrangement (Scheme 15). The preferred chair-like transition state may be attributed to
eclipsing interactions present in any boat-like transition state.

16

Based on the high internal asymmetric induction achieved for the reaction of the enolate derived from EN-2-butenyl-N-butylpropamide E-39, and taking advantage of the trivalent nitrogen atom, Tsunoda
extended the reaction to amide enolates containing chiral N-alkyl groups.

37

They found that the α-methyl

benzyl amine moiety directed rearrangement of carboxamide E-enolate 42 to the corresponding synamides 43 in 85% yield (Scheme 16). The anti-amide isomers were not detected, showing that the
reaction likely proceeded via a chair-like transition state. To date, the rationale for the relative
diastereoselectivity preference for syn-amide 43b over the syn-amide 43a (91.5:8.5) is still unclear.
38

Tsunoda also investigated the effect of other chiral auxiliaries attached to the carboxamide 42.

In most

of cases, S- configured auxiliaries generated the syn-amides in 66-90% yield and 70-84% de.

17

Tsunoda’s group has applied the asymmetric amino-Claisen rearrangement of different types of
carboxyamides for the synthesis of several natural products. Including antibiotic (-)-antimycin A3b.

39

Amide 44 was made from from (R)-(+)-phenethylamine and acrolein via a condensation-acylation
36

sequence (Scheme 17). Using standard conditions,

the rearrangement of amide 44 produced a mixture

of four diastereomers, from which the major syn (7S,8R; 7R,8S)-isomers 45 were isolated by SiO2 column
chromatography as an inseparable 82:18 mixture. Iodolactonization and subsequent reductive removal of
the iodide afforded lactone 46, which constitutes the C5-C8 fragment of the natural product 47.

18

It has also been shown that this rearrangement reaction is highly facilitated by the presence of a hydroxy
40

or an amino group at the α-position of the acyl group.

The [3,3]-sigmatropic rearrangement amide

products 49 were formed through the rearrangement of the corresponding enolates generated by the
treatment of carboxamides 48 with LDA or LHMDS in THF or toluene (Scheme 18).

19

Excellent syn selectivity (98:2) was observed for nearly all cases. Placing the OH and NH 2 group at the
α-position of acyl group facilitates the rearrangement. This was attributed to the possible lithium chelate
formation species between the enolate oxygen and α-heteroatom, such as 50 (inset). When the OH or
NH2 group is blocked by other functionality decelerates the reaction, in fact, the NBoc protection did not
give any rearrangement product. Also, trapping of enolates as TMS N,O-ketene acetals and subsequent
thermal rearrangement resulted in lower yield and selectivity as in α-alkyl derivatives, contrary to the
reaction of ester enolates where their silyl enolate trapping is usually necessary for good results.

This asymmetric amino-Claisen rearrangement has been successfully employed in the construction of the
41

C4-C5 sterogenic centers in the total synthesis of the natural product (+)-brefeldin C (54).

Thus the

o

rearrangement of 2-hydroxyacetamide 51 using 2.5 equivalents of LHMDS at -78 C and then heating at
o

65 C for 36 hours afforded a separable mixture of the amides 52a and 52b in 15:85 ratio, giving the
desired amide 52b as a major product. Hydroboration-oxidation of the isolated amide 52b followed by
acid catalyzed yielded the lactone 53, which constituted C3-C10 fragment of the natural product 54
(Scheme 19).

20

Another interesting application of the amino-Claisen rearrangement of amide-enolates was the
asymmetric construction of the quaternary carbon center in the total synthesis of (+)-α-cuparenone.

42

Previous studies demonstrated that the enolate of N-(E)-crotyl-N-(S)-phenylethylpropanamide 55 needed
excess LHMDS in order to undergo the rearrangement in high yield and stereoselectivity (Scheme 20).

43

By contrast, a complex mixture of products was obtained using 1.5 equivalents of LHMDS.

21

Based on these results, the amino-Claisen rearrangement of p-tolylpropanamide 58 containing an (R)phenylethyl moiety on the amide nitrogen was employed as a key step in the installation of one of the
quaternary centers presents in (+)-α-cuparenone. Initially, a complex product mixture was obtained when
the p-tolylpropanamide 58 was treated with 3 equivalents of the LHMDS. However, the addition of 20
equivalents of LHMDS afforded the desired rearrangement products with 83% yields and 88:12
stereoselectivity (Scheme 21, Table 1, entry 5).

Table 1. Results of amino-Claisen rearrangement studies of crotylamide 58
LHMDS (eq)

LiCl (eq)

Yield (%)

Ratio (2S/2R)

1

3

-

a

-

b

-

2

5

-

a

57

77/23

-

a

68

87/13

-

a

74

88/12

a

83

88/12

Entry

3

10

4

15

5

20

-

6

10

5

77

90/10

10

83

88/12

7
a

c

10
b

c

None, complex mixture, Not determined

The reason why the addition of excess base favored the rearrangement of this crotylpropanamides is
unclear. Tsunoda’s group suspected that one of the undesired reactions could be due to the
decomposition of the enolates of the carboxamides via ketene formation. Thus, they made N,Ndibenzylpropanamide 61 as a model compound to study the decomposition pathways. Initially, they
o

recovered 83% of 61 when it was treated with 1.5 equivalents of LHMDS at 80 C for one hour, but when
o

the reaction was conducted at 120 C for the same time, only 46% of 61 was observed. On the other

22

o

hand, 86% of the propanamide 61 was recovered when the reaction was performed at 120 C for an hour
o

using five equivalents of LHMDS. These results indicated that the decomposition occurred at 120 C, the
same temperature at which the rearrangement took place. Excess LHMDS apparently stabilized the
amide enolates and consequently prevented their decomposition to ketene and other undesired side
reactions (Scheme 22).

Studies of ketone alkylation reactions reported by Streitwieser et al.

44,45

suggested that the aggregate

formed by the close proximity of two or more lithium cations to the enolate oxygen make the α-carbon of
the lithium enolate electron deficient, thus making the enolate a poorer nucleophile. Therefore,
Tsunoda’s group suggested that the presence of large amounts of LHMDS delayed the decomposition of
the amide enolate aggregates, thus favoring the amino-Claisen rearrangement. They also found that
addition of lithium salts instead of LHMDS reduced the amount of base required for the rearrangement.
After trying several different types of lithium salts, the best result was attained using 10 equivalents of LiCl
with 10 equivalents of LHMDS (Table 1, entry 7).

Reduction of amide 62 with diphenylsilane-Ti(O-iPr)4 followed by cyclization in presence of Wilkinson’s
catalyst afforded the cyclopentanone ring intermediate 63. Alkylation of 63 with methyl iodide and NaH
gave the cyclopentanoid natural product 64 (Scheme 23).

23

Another example of the amino-Claisen rearrangement of amide enolates was the preparation of the Nmethyl-δ-hydroxyisoleucine amino acid 69 as a key intermediate in the total synthesis of marine cyclic
46

depsipeptide halipeptin A-1(70).

A separable mixture of diastereomers was obtained after exposing (Z)-

2-butenylpropanamide 65 to 2.4 equivalents of LHMDS. Moderate diastereoselectivity was observed
(66/67=3:1), but 52% of the major isomer 67 was isolated by recrystallization. Cleaving the chiral
auxiliary of 67 under acidic conditions and subsequently esterification with CH2N2 gave the methyl ester
68 (Scheme 24).

24

2. Asymmetric Amino-Claisen Rearrangement of Silyloxyallyl-propanamide 34
As we mentioned before, Tsunoda’s group reported the [3,3] sigmatropic rearrangement of amide enolate
71 to generate 2,3-syn pent-4-enamides 45 (Scheme 25) to construct the (7S,8R)-stereogenic centers as
a key step in the total synthesis of antimycin A3b.

25

Due to the close structural similarity between Tsunoda’s pentenamides 45 and our pentenamides 35
(Scheme 25, inset), we considered that this asymmetric strategy could be efficiently applied to prepare
amide 35 with the (14S,15R)-configuration present in the antascomicin B (1) (cf. Scheme 13).
Additionally, we sought explore the scalability of the amino-Claisen rearrangement. The longest scale
that had been reported for the preparation of silyloxypropene amine 73 was 100 mg (0.82 mmol) and 230
mg (0.53 mmol) for the rearrangement of amide 44 (Scheme 26).

26

Our approach to install the desired stereocenters started with the preparation of the precursor to the
amino-Claisen rearrangement, silyloxyallylpropanamide 34. Following Tsunoda’s protocol, the first step
in the synthesis was the silylation of (S)-methylbenzylamine (33) with trimethylsilyltriflate (TMSOTf)/DBU
38

at 0 °C in ether (Scheme 27).

Then, in situ addition of triisopropylsilyltriflate (TIPSOTf) and acrolein

afforded the crude product 73, which was isolated by silica gel flash chromatography. The E1

3

configuration of the double bond in the amine product was verified by H-NMR spectroscopy ( J-trans =
14.9 Hz).

27

Table 2. Limitation in the preparation of silyloxypropene amine 73
Entry

Amine 33, g (mmol)

Amine 73 % Yield

1

1.0 (8.25)

42 – 58

2

1.5 (12.3)

32 – 44

3

2.5 (20.6)

28 -36

4

3.5 (28.8)

15 – 32

5

4.0 (33.0)

5 – 10

6

5.0 (41.2)

5–8

Increasing the amount of amine 33 beyond 8.25 mmol resulted in a steady decrease in the yield (Table
2). Also, a complex mixture and formation of TIPSOH were observed each time the reaction was
performed. Initially, we suspected that the lowered yield was due to an inefficient in situ silylation of
47

amine 33. Therefore, we purified silylamine 72 by vacuum distillation (Scheme 28).

Interestingly, using

purified silylamine 72 gave lower yield than the in situ reaction (Table 3).

28

Table 3. Results of making amine 73 from silylamine 72
Entry

TMS-amine 72, g (mmol)

Amine 73 % Yield

1

1.0 (5.2)

20 – 28

2

3.0 (15.1)

19

3

6.5 (33.6)

18

It is unclear why the conjugate addition of the in situ formed silylamine 72 provided much better yields
than the pure silylamine 72 (Table 3). However, two different possibilities could explain these results.
First, each time the reaction was performed large amounts of TIPSOH were isolated. Thus, the lower
yields of the reaction could be caused by the fast quenching of the TIPSOTf to TIPSOH. Second,
polymerization of acrolein could be also responsible for the lower efficiency of the conjugate addition
reaction.

In order to produce multigram amounts of amide 34, we performed multiple up to 1.5 g (12.3 mmol)
parallel reactions (cf. Scheme 27, table 2, entry 2). After isolating the combined amine 73 by flash
o

chromatography, acylation of 73 with propanoyl chloride in the presence of triethylamine in CH2Cl2 at 0 C
generated 96% of allyl propene amide 34 (Scheme 29). According to analysis of NMR data, amide 34
was sufficiently pure that further purification was not necessary. Similar results were obtained when we
scaled the acylation reaction of 73 to 9.5 g (28.4 mmol).
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Having the desired precursor 34 in hand, we carried out the deprotonation with lithium
o

hexamethyldisilazide (LHMDS) in toluene at -78 C (Scheme 30). After 30 min, the reaction mixture was
o

allowed to warm to rt, and sealed in a pressure vessel. Heating of sealed solution at 120 C for 6 h
afforded a mixture of the rearranged β-silyloxy amides 35 in 82 % yield.

30

Two diastereomers were formed in a 4.2:1 ratio according to GC analysis of a crude sample of the
reaction mixture. Based on Tsunoda’s

34-38

precedent, we presumed that the syn-amides 35a and 35b

were formed. However, in our hands no other isomer was observed.

Using silica gel column chromatography we were able to enrich the major diastereomer 35a to 96:4 ratio
according with GC analysis. Moreover, X-ray crystallographic analysis of the desilylated amide 75
confirmed the syn relative configuration of the rearrangement amides (Figure 1).

Although the above protocol provided good yield of the desired β-1,2-syn silyloxyamides 35, the moderate
diastereoselectivity in the amino-Claisen rearrangement step motivated us to try to improve it.

Our first attempt to achieve this goal was to use potassium hexamethyldisilazide (KHMDS) instead of
-

LHMDS, in the presence of 18-crown-6. We reasoned that a more reactive anion ( HMDS) could facilitate
the formation of the intermediate enolate 76 and consequently generate better diastereoselectivity of
amides 35a,b (Scheme 31). However, GC analysis showed the dr of 35a,b decreased drastically to
2.5:1.
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Collum et al. have investigated solvent dependence of LHMDS structure in the enolization of ketones and
esters.

48, 49

They found that, in the presence of triethylamine (Et3N/toluene), the enolization of 250

methylcyclohexanone is > 100 times faster than the same enolization made in neat THF (Scheme 32).
Mechanistic studies also revealed that the Et3N-mediated rate acceleration resulted from severe steric
effects affiliated with solvation in the reactant that are relieved in the transition state structure 79a. By

contrast, the LHMDS/THF-mediated enolizations proceed through a conventional monosolvated-dimer
based transition structure 79b.

32

Collum has also reported the selectivities and reactivities of THF and Et3N-solvated lithium enolates in the
51

Ireland-Claisen rearrangement (Scheme 33).

They found that enolization of ester 80 using

LHMDS/Et3N (1/10 ratio) in toluene generated E-81 faster than using LHMDS/THF (1/10 ratio) in
Et3N/toluene. Qualitative rate studies showed that Et3N-solvated enolates rearranged approximately 20
times faster than with added THF.

33

Professor David Collum suggested that the diastereoselectivity of the amino-Claisen rearrangement of
amide 34 would possibly be improved by generating the amide enolate 74 in presence of excess of Et3N
(personal communication).

o

Enolization of amide 34 with 2 eq of LHMDS and 5 eq of Et3N in toluene at -78 C showed no
improvement of the diastereoselectivity (Table 4, entry 2). However, use of 10 eq of Et3N afforded a 7.7:1
dr of 35a and 35b in 86% isolated yield. Use of 1.5 eq of LHMDS and 10 eq of Et3N provided the same dr
as when the rearrangement was carried out in the absence of Et3N. Two equivalents of the LHMDS were
required to provide 7.7:1 dr.
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Table 4. Diastereoselectivity optimization of the amino-Claisen rearrangement

Entry

Base (eq)/additive (eq)

% Yield

syn-dr ratio

1

LHMDS (1.5)

78

4.2 : 1.0

2

LHMDS (2.0)/Et3N (5.0)

82

4.0 : 1.0

3

LHMDS (2.0)/Et3N (10.0)

86

7.7 : 1.0

4

LHMDS (2.0)/Et3N (15.0)

84

7.7 : 1.0

5

LHMDS (2.0)/Et3N (20.0)

85

7.7 : 1.0

6

LHMDS (1.5)/Et3N (10.0)

80

4.0 : 1.0

Using the optimized reaction conditions (Table 4, entry 3), we were able to scale the reaction to 9.6 g
(24.6 mmol) of amide without decreasing the diastereoselectivity. The major diastereomer 35a was
isolated by column chromatography.

Our next objective was to install the C11/C14 relative configuration for the C10-C16 fragment of
antascomicin B. In order to achieve this goal, we proposed to use ring-closing metathesis methodology
to establish the 1,4-anti stereorelationship.
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E. Attempts to Build the 1,4-anti (C11-C14) Stereorelationship via Ring-Closing Olefin Metathesis
1. Efforts to Construct the β,γ-Unsaturated Lactone 37 by Ring-Closing Metathesis
Ring-closing metathesis (RCM) of unsaturated esters has been successfully used to obtain unsaturated
51-54

δ-lactones as key intermediates in the total synthesis of bioactive natural products.

For example, the

Nicolaou group’s asymmetric synthesis of the B and C pyran rings of the antibiotic everninomicin used
52

ring-closing olefin metathesis of acrylate 84 to provide α,β-unsaturated δ-lactone 85 (Scheme 34, eq a).

Grubb’s first (G-I) and second generation (G-II) catalyst complexes have been also effectively utilized by
Wang et al. in the formation of β,γ-unsaturated methyl-substituted δ-lactones 87 (Scheme 34 eq b).

53, 54

Most of the RCM products of the stereo-defined allyl esters 86 were produced in high yields using either
catalyst GI or GII. The main difference between the two reactions was the catalyst loading (G-I=5 % mol;

36

G-II=1 % mol). To prevent the formation of cross-metathesis byproducts, the concentration of the RCM
reactions was approximately 0.01 M.

The synthesis of (E)-δ-alkenyl-β,γ-unsaturated δ-lactones via tandem ring-closing/cross-metathesis
(RCM/CCM) in the presence of Grubbs type II catalyst has been investigated by Piva’s group (Scheme
55

35).

They found that the RCM/CCM of pentadienyl ester 89 with olefins 88 using 5% of the catalyst in
o

-2

DCM at 50 C for 4 h had to be conducted in highly dilute solutions (10 M); otherwise, complex mixtures
were observed.

The few examples described above suggest that the RCM could be a convenient route to unsaturated δlactones. Thus, our first step in the synthesis was the preparation of RCM precursor 36, which
commenced with desilylation of TIPS ether with a 5:95 solution of hydrofluoric acid and acetonitrile to
afford allyl alcohol 75 (Scheme 36). The best yield of the desired allylester 36 was obtained by treatment
of alcohol 75 with 2-methyl-3-butenoic acid and dicyclohexylcarbodiimide (DCC) in the presence of base
and catalyst (Scheme 36, Table 5, entry 2).
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Table 5. Acylation reaction of allyl alcohol 75
%Yield

SM
recovered
(%)

38

0

o

57

18

o

40

21

o

52

19

Entry

Acylating reagent
(eq)/catalyst (eq)

Base (eq)

Reaction
Conditions

1

92 (1.5)/no catalyst

n-BuLi (1.1)

-78 C to rt 10 h

2

93 (1.0)/DMAP (0.5)

DCC (1.1)

0 C to rt 72 h

3

93 (1.1)/DMAP (3.5)

DCC (2.5)

0 C to rt 20 h

4

92 (1.2)/no catalyst

TEA (1.2)

0 C to rt 24 h

o
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Unfortunately, under standard RCM reaction conditions the allyl ester 36 was found to be unreactive
(Scheme 37). Increasing the loading of catalyst and varying the concentration of the reaction mixture
gave only recovered starting material and a complex mixture.

Similar results were obtained when the reaction mixture was heated under reflux in DCM for 19 h (Table
6, entries 1-5). When the reaction was performed in toluene using 16% of Grubbs’ II catalyst, and heated
o

at 80 C for 24 h, less than 5% of the cyclized product was observed, accompanied by a complex
unidentifiable mixture (Table 6, entry 8). If the reaction mixture was maintained at rt for 24 h in presence
of 15% of G-II 60 % of the starting allyl ester 36 was recovered (Table 6, entry 9).
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Table 6. RCM reaction conditions of the allyl ester 36
Entry

LnRu=CHPh (%)

Solvent

Reaction
conditions

Result

1

HG-II (0.9)

DCM

rt, 24 h

SM + complex mixture

2

HG-II (3.0)

DCM

rt, 24 h

SM + complex mixture

3

HG-II (5.0)

DCM

50 C, 19 h

4

HG-II (7.0)

DCM

50 C, 19 h

5

HG-II (7.0)/Ti(OiPr)4
(0.3)

DCM

50 C, 19 h

6

G-II (6.0)

PhMe

80 C, 24 h

7

G-II (8.0)

PhMe

80 C, 24 h

8

G-II (16.0)

PhMe

9

G-II (15.0)

DCM

o

SM + complex mixture

o

SM + complex mixture

o

SM + complex mixture

o

complex mixture

o

37 (<< 2 %) + complex mixture

80 C, 24 h

o

37 (<< 5 %) + complex mixture

rt, 24 h

60 % recovery of SM

We do not have an explanation why the RCM process of the allyl ester 36 failed. The RCM may fail when
alkenes are either sterically hindered or electronically similar. Grubbs has reported that the efficiency of
cross metathesis of α,β-unsaturated amides with terminal olefins is affected by the substituents on the
amide nitrogen.

56

For example, the cross-coupling reaction of dimethylacrylamides 94 and 95 with

styrene resulted in lower yields (Table 7, entry 1-2). In contrast, higher yields of cross products were
obtained when phenylacrylamides 96 and 97 were used (Table 7, entry 3-4). They suggested that the
amide carbonyl group may chelate to the Ru center, and more electron-rich amides have a higher
propensity for chelation (Scheme 38, eq a). We speculate that the amide carbonyl group in our substrate
might trap the catalyst by forming the six member chelated complex, and consequently stop the
metathesis process (Scheme 38, eq b).
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Table 7. Cross metathesis reaction of α,β-unsaturated amides

Entry

Acrylamide

% yield of CM with styrene

1

25

2

33

3

69

4

87

All reactions were made using 5 % of G-II catalyst and 1.9 eq of styrene (0.2 M in
DCM).
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2. Ring Closing Metathesis of Allylester 36 in Presence of Diallylmalonate
The problem of unreactive alkenes has been overcome in some cases by the generation of a more
reactive methylidene carbene. For example, in 1998, Mori et al.

57

reported that the treatment of enyne

98, having no substituent on the alkyne, with G-I at room temperature yield only 21 % of diene 99
(Scheme 39). However, when the reaction was carried out under an atmosphere of ethylene gas, the
reaction generated 90 % yield of diene 99.

This remarkable effect of the ethylene on the yield of Ru-catalyzed enyne RCM reactions was
mechanistically explained by a continual reactivation of the ruthenium catalyst keeping it an active
through generation of ruthenacyclobutane 106 which is in a state of equilibrium with methylidene
ruthenium complex 101 and ethylene gas (Scheme 40). Thus, keeping the equilibrium towards
intermediate 106 the active catalyst can readily react with the corresponding starting material 100. In the
absence of ethylene, the methylidene complex 101 can react with diene 103 to generate a less active
species such as 104 and 105.

42

In our case, we applied the same concept by using diallylmalonate 107 which can react quickly with both
G-II and HG-II catalysts

58

and consequentially deliver the ruthenium to the olefin 36 to generate the

ruthenium olefin intermediate 110 through ejection of the by-product cyclopentene carboxylate 109
(Scheme 41). Then, cyclization of the active olefin 110 will afford the desired δ-lactone 37.
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The diallylmalonate substrate 107 was prepared from diethyl malonate following standard conditions.

59

When the mixture of 107 and the corresponding ester 36 were treated with 12 mol % of either G-II or HGo

II catalyst (0.0032 M in toluene, sealed pressure vessel, 80 C) the cyclized product 37 was obtained in
73% and 77% yield, respectively (Table 8, entries 1-2). Unfortunately the efficiency of the RCM process
depends on the concentration of the reaction mixture, which has to be very dilute. When we performed
the reaction at higher concentrations, the major product observed was the RCM product of the
diallylmalonate 107, and also some starting material was recovered (Table 8, entries 3-5). This is a very
limiting factor because we would need very large amounts of solvent to scale up the reaction. For
example, the largest scale setting on this RCM process was 100 mg and 110 mL of solvent was needed
to obtain cyclic product 37. Thus, we considered this methodology was not viable in our case.
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Table 8. Efforts to improve the RCM process to get δ-lactone 37

Entry

LnRu=CHPh (%)

Concentration
(M)

Reaction
Conditions

1

G-II (12.0)

0.0032

80 C, 2 h

2

HG-II (12.0)

0.0032

80 C, 2 h

3

G-II (12.0)

0.0063

80 C, 2 h

4

HG-II (5.0)

0.0079

80 C, 6 h

5

G-II (5.0)

0.0079

80 C, 6 h

6

G-II (12.0)

0.0079

80 C, 2 h

Result

o

37 (73 %)

o

37 (77 %)

o

36 + 109 + complex mixture

o

37 (<< 5%) + complex mixture

o

complex mixture

o

109
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F. Cross Metathesis Attempt to Install the 1,4-anti-Configuration of the C10-C16 Fragment
We also examined cross metathesis (CM) between the amino-Claisen product 35a and carboxylic acid 93
as an alternative to RCM. Unfortunately, no reaction was observed in any of the attempts using Grubbs’
type II (Scheme 42).

Table 9. Results of the CM of amide 35a with olefin 93
Entry

LnRu=CHPh (%)

Solvent

Reaction
Conditions

1

G-II (5.0)

DCM

50 C, 12 h

2

G-II (7.0)

DCM

50 C, 24 h

3

G-II (7.0)

DCM

50 C, 72 h

4

G-II (12.0)

PhMe

80 C, 3 h

5

G-II (12.0)

PhMe

100 C, 9 h

Result

o

Recovered SM

o

Recovered SM

o

Recovered SM

o

o

Recovered SM
Recovered SM
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G.

Efforts to Introduce the 1,4-anti (C11-C14) Stereorelationship through Allylic Diazene

Rearrangement
The ene reaction, originally defined by Alder et al,

60

involves the addition of an alkene possessing an

allylic hydrogen (ene) to a compound having electron-deficient multiple bonds (enophile), following in
most cases a thermal concerted [2πs + 2πs + 2σs] pathway. The retro-ene reaction that involves the
elimination of molecular nitrogen from 1-diazo-2-propene to obtain propene is called the allylic diazene
rearrangement (ADR) (Scheme 43).

3

The ADR has been employed to install sp stereocenters in a variety of cyclic systems.
there were no examples in acyclic systems prior to the reports from our group.

63

61, 62

However,

We demonstrated that

1,4-syn- or 1,4-anti acyclic stereorelationships can be generated in high yield and diastereoselectivity by
one pot reduction/allylic diazene rearrangement of α,β-unsaturated tosyl hydrazones. For example, the
treatment of tosyl hydrazone 112 with catecolborane and silica gel at low temperature for 2 h, followed by
addition of NaOAc and heating the reaction mixture for 6 h, afforded 1,4-syn-E-2 alkenyl product 113 in
92 % yield and ≥ 20:1 dr. The 1,4-syn- products 114 and 115 were obtained in the similar fashion
(Scheme 44).

47

We also reported examples of the formation of 1,4-anti alkenes 117 in good yield and ≥ 20:1 dr, from Zalkene α,β-unsaturated tosyl hydrazones 118 (Scheme 45).

Therefore, we recognized that we could use the ADR to install the C11/C14 relative configuration for the
C10-C16 fragment. Retrosynthetically hydrazone Z-118 could be constructed from alkyne 119 by Pd
catalyzed cross coupling addition of acetylenes.

64

This target molecule 119 could be formed by acylation
68

of Weinreb amide 120 with propynyllithium, following by addition of tosyl hydrazide.

The amide 120

could be derived from carboxylic acid 120 which could be obtained by oxidative cleavage of the terminal
olefin of the amino-Claisen product 35a (Scheme 46).

48

1. Attempts to Prepare the Silyloxybutanoic Acid 120 by Ozonolysis
The first step to obtain carboxylic acid 120 involved the oxidation cleavage of the terminal olefin of the
amino-Claisen product 35a with a stream of ozone in methanol followed by direct reduction-oxidation
65

protocols.

However, the expected acid 120 was not formed and 53 % of the starting olefin was

recovered (Table 10, entry 1). Surprisingly, in all attempts where the alkene was exposed for longer
periods of time to ozone, or using a mixture of MeOH-DCM solvents, we recovered starting material in 4153 % yield. Furthermore, the TIPS group was also cleaved and 16-20 % of the hydroxy acid 121 was
generated (Table 10, entries 2-6).
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Table 10. Attempts to prepare butanoic acid 120 via ozonolysis

Entry

O3 (min)

Solvent

(Me)2S (eq)

SM (%)

Hydroxy acid 121 (%)

1

20

MeOH

6.0

53

---

2

45

MeOH

6.0

41

18

3

60

MeOH

6.0

43

16

4

90

MeOH

6.0

46

19

5

45

MeOH-DCM
(1:1)

6.0

6

45

MeOH-DCM
(1:1)

50.0

41
44

16
19

In order to better understand what was occurring in the reaction, we simplified the ozonolysis of alkene
35a by not performing the final oxidation step. Ozonolysis of a methanolic solution of the alkene 35a
followed by reduction with dimethyl sulfide (DMS) resulted in low yield (≤ 16 %) of hydroxyaldehyde 122
and ≤ 42 % yield of recovered starting material (Table 11, entries 1-3). Neither use of a large excess of
DMS nor use of a MeOH-DCM solvent mixture improved the results (Table 11, entries 4-5).
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Table 11. Reductive ozonolysis results of the olefin 35a

Entry

O3 (min)

Solvent

(Me)2S (eq)

Results: 35a (%), 122 (%)

1

45

MeOH

6.0

35a (42), 122 (14)

2

60

MeOH

12.0

35a (38), 122 (16)

3

60

MeOH

36.0

35a (41), 122 (14)

4

60

MeOH-DCM (1:1)

6.0

35a (44), 122 (15)

5

60

MeOH-DCM (1:1)

36.0

35a (41), 122 (14)

These results suggest that the cleavage of the TIPS group occurred subsequent to reaction of the alkene
with ozone. Based on these observations and the Criegee mechanism for the ozonolysis,

66-68

we

speculate two different reasons that could explain this results. First, the removal of the TIPS group
probably happened in the reduction step of the secondary ozonide. Maybe it is the silyl group which
induced the reduction to get the hydroxyaldehyde 122 (Scheme 47). The last could be a reason why
using 6.0 eq or 36.0 eq of the DMS did not represent any important difference in the results.
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The second speculation is based on a Greco et al. report.

69

They found that standard saponification

conditions and mild acidification of α-silyloxy homo-arginine derivative 123 generated the unexpected
desilylated amino acid 124 (Scheme 48). In order to explain this unusual desilylation reaction they
undertook systematic studies by exposing related substrates to the saponification/acidification procedure
(Table 12).
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Table 12. Saponification process of amino acid derivatives 125-128
Entry

1

Substrates

products

125

125a

2
126

no reaction

3
127

4
128

128a

Reaction conditions: LiOH (3 eq), dioxane:water (9:1) and 50% aq solution of AcOH
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According with their results, they considered that intramolecular hypervalent silicon species (Scheme 50,
eq a) was not formed since saponification of ester 125 yielded silyl-protected acid 125a (Table 12, entry
1). The desilylation process appears to be unrelated to the amino acid side chain, because the major
product of saponification of alanine derivative 126 gave desilylated acid 126a (Table 12, entry 2). Thus,
they suggested that hydrogen bonding between the α-amino hydrogen and the carbonyl oxygen is crucial
to facilitate protondesilylation (Scheme 49, eq b). Thus, saponification of proline 128, which cannot
experience this hydrogen bond, generated silylated acid 128a (Table 12, entry 4). Based on these
findings, in our case, we speculate that the secondary ozonide was not formed and the loss of the TIPS
group probably happened in the reduction step of the primary ozonide. Hydrogen bonding between the
NH proton and the silyl ether oxygen may promote the desilylation of the TIPS-protected amide (Scheme
49, eq c).
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2. Ozonolysis of Amide 35a in Presence of Pyridine
There are several reports performing the ozonolysis of alkenes in presence of pyridine to direct the
formation of ketones or aldehydes.

70-72

For example, it was found that the selective cleaving of the least

substituted alkene in the ozonolysis reaction of 4,22-stigmastadien-3-one 129 in presence of pyridine lead
73

the resulting aldehyde 130 in high yield upon reduction (Scheme 50).

Performing the reaction in

absence of pyridine generated a mixture of cleavage products.

Although there is not clear explanation what is the role of the pyridine in the ozonolysis reaction, the
authors postulated two possible explanations. First, the nucleophilic pyridine could react with ozone to
form a less electrophilic pyridine-ozone species. This adduct would be a weak oxidant and consequently
enhance the chemoselectivity (Scheme 51, eq a). Second, the nucleophilic pyridine could directly attack
the electrophilic carbon of the carbonyl oxide and following rearrangement generate the aldehyde and
pyridine N-oxide (Scheme 51 eq b). However, monitoring the ozonized tetramethylethylene reaction in
the presence of stoichiometric amounts of pyridine by NMR spectroscopy did not show the formation of
pyridine oxide. Instead, most of the pyridine remained unchanged during the cleavage reaction.

74
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Appling these ozonolysis reaction conditions to olefin 35a (Scheme 52), we found that in all cases ~ 35 %
yield of the silyloxyaldehyde 132 was obtained and ~ 20 % yield of the starting material was recovered.
1

Spectroscopic analysis of the H and

13

C NMR spectra showed clearly that the silyloxyaldehyde 131 exist

exclusively in its tautomeric σ-hydroxy lactam form 132 (Scheme 53).

56

1

Scheme 53. H and

13

C-NMR spectra of the σ-hydroxy lactam 132
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These experiments suggest that the pyridine plays a critical role, not only in the formation of the σhydroxy lactam product, but also in the stability of the TIPS ether. Recently, Dussault et al. proposed that
pyridine acts as a catalyst in the ozonolysis reaction.

75

They observed that: 1) the reaction of different

olefins in the presence of pyridine and methanol always yielded hydroxyperoxyacetals (Scheme 54 path
a), 2) isolated 2° ozonides did not react with pyridine to produce carbonyl products (Scheme 54, path b),
and 3) pyridine did not reduce the carbonyl oxide intermediate to produce aldehyde and pyridine oxide
(Scheme 54, path c). They concluded that a feasible mechanism would involve the nucleophilic addition
of pyridine to the carbonyl oxide to generate zwitteron 133. Reaction of this zwitteron with another
molecule of the carbonyl oxide would result in the formation of the zwitterionic peroxyacetal 134, which
could fragment to a molecule of O2, two carbonyl groups, and pyridine (Scheme 54, path d).

58

Although Dussault’s suggested mechanism is consistent with our speculation that the TIPS group
cleavage would occur in the reduction step of the secondary ozonide (cf. Scheme 47). It seems unlikely
that the 2° ozonide would prefer to react with a hindered silyl ether if it would not react with a much more
nucleophilic pyridine.

3. Other Oxidation Efforts to Form Carboxylic Acid 127 and Aldehyde 137
One of the most frequently employed procedures to obtain carboxylic acids from alkenes is the RuCl3NaIO4 oxidation in the CCl4-CH3CN solvent system reported by Sharpless et al.

76, 77

Applying this

protocol to alkene 35a using several reaction conditions only produced unidentified complex mixtures.
Similarly, treatment of olefin 35a with OsO4-NaIO4 in the presence of 2,6-lutidine in dioxane-water

78

likewise led only complex mixtures (Scheme 55).
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H. Third Generation Route to Construct the C10-C21 Fragment of Antascomicin B
Due to the low reactivity of the terminal olefin of the amino-Claisen product 35a in the oxidations, we
sought another strategy to the C10-C21 fragment. The plan was to establish the desired C11
configuration using an Evan’s alkylation reaction with iodo undecadiene 136, which could be generated
from pyranone 135 using standard protocols. Pyranone 137 can be obtained by acid hydrolysis of the
hydroboration/oxidation product of the rearranged amide 35a (Scheme 56).

1. Preparation of Silyloxypyranone 137 through Hydroboration/Oxidation
One of the most useful methods to convert an alkene into an alcohol is hydroboration/oxidation.

79-81

One

feature of this reaction is the regioselective addition of borane reagents such as dicyclohexyl borane to
provide anti-Markovnikov alcohols.

The hydroboration oxidation of our substrate started with the in situ preparation of (Chx)2BH, which
precipitates as white crystals when 2.0 eq of cyclohexene is treated with 1.0 eq of BH 3·SMe2 in ether at 0
o

82

C.

Addition of a THF solution of olefin 35a to the (Chx)2BH suspension followed by oxidation produced

60

the desired alcohol 138. Initially, we only obtained 30 % of the product, while 57 % of the starting olefin
was recovered (Table 13, entry 1).

Table 13. Hydroboration/oxidation of olefin 35a

Entry

35a g (mmol)

HB(Chx)2 (eq)

% yield of 138

1

0.5 (1.28)

1.0

30

2

1.0 (2.56)

2.0

52

3

1.0 (2.56)

3.0

78

4

1.0 (2.56)

4.0

76

5

4.0 (10.3)

3.0

72

The addition of 3.0 eq of borane to 35a furnished 78 % of alcohol 138, which was the highest yield.
Addition of 4 eq did not improve the yield (Table 13, entries 3-4). We were able to scale this process to
4.0 g (10.3 mmol) and obtained 72% yield of alcohol. However, we have been unable to reproduce these
results every time the reaction was performed. Using exactly same reaction conditions, we sometimes
obtain ~ 10 % of the desired alcohol and ~ 70 % of an unknown compound.

Our next objective was cleavage of the amide functionality of 138 to a lactone, carboxylic acid, or ester.
Typical acidic or basic hydrolysis returned only starting material (Scheme 57).
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Multiple reports has shown that derivatization of secondary amides to N-nitrosoamides is a mild
83-86

procedure to cleave amide bonds.

For example, in the final step of the synthesis of propionic acid

142, the amide linkage was cleaved without racemization via nitrosoamide intermediate 141, upon
alkaline hydrolysis resulted in 70 % yield of 142 (Scheme 58).

In our case, hydroxyamide 138 was resistant to treatment with NaNO2 in presence of acetic acid and
acetic anhydride, returning only unreacted starting material (Scheme 59). Amide 35a behaved similarly.
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Grieco et al.

87

reported that N-Boc derivatives of lactams and secondary amides undergo regioselective

hydrolysis using LiOH or methanolysis to yield amino acids or esters respectively (table 14).

Table 14. Hydrolysis of N-Boc derivatives of lactam and secondary amides
Entry

Amide

N-Boc amide, (% yield)

Cleaved product, (% yield)

1

2

3

Unfortunately in our case, it was not possible to convert hydroxyamide 138 into its N-Boc derivative 144
1

efficiently. According with the crude H-NMR data, we always observed less than 10% of the N-Boc
amide product after treating 138 with LHMDS, Boc anhydride (Boc2O) and DMAP in THF. Moreover,
when we tried to purify the N-Boc derivative 144 from the crude mixture by column chromatography, we
were able to recover the starting amide, but we never isolated 144. The same result was obtained after
several attempts using different reaction conditions (Scheme 60). Amide 35a was also unreactive using
same reaction conditions.
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Our next approach to amide cleavage was to perform a cyclization in acid medium to generate the
corresponding lactone. Although the hydroxyamide 138 could be susceptible to β-elimination reactions,
heating 138 in presence of 1.1 equivalent of tosic acid (PTSA) in refluxing benzene for 15 min furnished
48 % yield of the desired silyloxypyranone 138. Additionally, 38 % of the starting amide was recovered
and no elimination product was observed. It is important to mention that heating the reaction mixture
longer than 15 min did not improve the yield (Table 15, entry 2-3). When scaled to 2.5 g (6.10 mmol), 46
% yield of the lactone product was obtained and 40 % of the hydroxyamide was recovered.

Table 15. Acid mediated cyclization of hydroxyamide 138

Entry

Reaction time (min)

137 % yield

% Yield brsm

1

15

48

86

2

30

45

85

3

120

47

86
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2. Efforts to Introduce the C17-C21 Hexadiene Arm via Grignard Addition
Having the silyloxypyranone 137 in hands, our next goal was to focus in installing the hexadiene fragment
(C17-C21) of antascomicin B. To accomplish this, we expected that the addition of the known acetylide
Grignard reagent 145 to the silyloxypyranone 137 and subsequent reduction would produce the
corresponding diene.

The Grignard reaction began with addition of the pyranone 137 to an ether solution of hexenyl
o

magnesium bromide (2 eq) at 0 C, which was previously formed in situ by the treatment of
88

allylmagnesium bromide with propagyl chloride.

After allowing the reaction mixture warming up to rt and

o

then stirring for 14 h at 50 C no desired product was obtained. Instead, most of the starting pyranone
was recovered (Table 16, entry 1-2). Treating pyranone 137 with 4.0 eq of the Grignard reagent gave a
mixture of products. Purification by silica gel column chromatography allowed recovery some of starting
material, and ca 27 % yield of impure hexenyl pyranol 146 (Table 16, entry 3 - 4). Use of CeCl3 did not
improve the results (Table 16, entry 6-7).

89, 90
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Table 16. Organometallic addition reaction of pyranone 137

o

Entry

145 (eq)

CeCl3 (eq)

Solvent

Temp C

Time

Results

1

2.0

--

THF-Ether

-10 to r.t

14 h

137 recovered

2

2.0

--

THF-Ether

-10 to 50

24 h

137 recovered

3

4.0

--

THF-Ether

-10 to r.t

14 h

146 (27 %) + 137 (18%)

4

5.0

--

THF-Ether

-10 to 50

14 h

146 (23 %) + 137 (19%)

5

6.0

--

THF-Ether

-10 to 85

12 h

complex mixture

6

3.0

3.0

THF

0 to r.t

6h

complex mixture

7

6.0

6.0

THF

0 to r.t

6h

complex mixture

We also tried saponification of the lactone to the corresponding hydroxyester 147, but the
silyloxypyranone 137 was extremely stable toward alkali conditions. Treatment of 137 with either
methanolic sodium methoxide or methanolic potassium hydroxide returned only starting material (Scheme
61).
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We next sought to install the C17-C21 hexadiene through the corresponding Weinreb amide. Most direct
conversions of lactones or esters into the corresponding N-methoxy–N-methyl amides have employed
trimethylaluminum-N,O-dimethylhydroxylamine hydrochloride (Me3AlCl-MeONHMe·HCl).
this procedure has been found not efficient for bulky lactones.
reported by Nakata research group.
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94

91-93

However,

Thus, an alternative methodology was

They found that sterically hindered lactones react smoothly with

dimethylaluminum chloride and N,O-dimethylhydroxylamine hydrochloride (Me2AlCl-MeONHMe·HCl) to
furnish the desired Weinreb amides in excellent yield.

Lamentably in our case, the aminolysis reaction of silyloxypyranone 137 with Me2AlCl (3 eq) and
MeONHMe·HCl (3 eq) in DCM resulted only in recovered starting material. Leaving the reaction mixture
for up to 24 h or up to 6 eq of dimethylhydroxylamine hydrochloride did not make any difference (Scheme
62).
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I.

Asymmetric Suzuki Cross-Coupling Strategy to Construct the C1-C21 Fragment of

Antascomicin B
Because of the aforementioned difficulties, we started to consider a fourth generation approach to the C1C21 fragment of the macrolide. We proposed that the C1-C16 fragment could be assembled from
tricarbonyl pipecolic carboxylate fragment I and boronate pentamide derivative fragment II by asymmetric
Suzuki cross-coupling methodology (Scheme 63).

This idea was based on studies by Fu et al. of a nickel-catalyzed enantioselective Suzuki alkylation of
racemic α-haloamides.

95

They established that NiBr2·diglyme and (S,S)-diamine ligand 151 could

catalyze cross-coupling of an γ-chloroamide 150 with TBSO(CH2)3-(9-BBN) to afford tertiary γalkylcarbonyl compound 152 with good enantioselectivity and yield (Scheme 64). Using the appropriate
chiral catalyst we could potentially join the fragments, and install the C11-C14 anti stereorelationship.
Fu’s asymmetric Suzuki reaction has been applied to structurally simple molecules. It would represent a
significant advance if we could apply Fu’s strategy to the coupling of more complex compounds such
fragments I and II.
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1. Attempts to Synthesize the Vicinal Tricarbonyl Region of Antascomicin B via Amide Bond
Formation
In order to establish the best reaction conditions to synthesize the vicinal diketo amide 155, we started
the synthesis using methyl ester 153 of the racemic mixture of the DL-pipecolic acid hydrochloride, which
was prepared quantitatively from DL-pipecolic acid hydrochloride under standard conditions.
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Then,

acylation reaction of 153 with the corresponding oxopentanoyl chloride 154 in presence of base and
catalyst was performed (Table 17).

The acylation reaction proved to be more problematic than we anticipated. First, standard acylation
reaction conditions gave moderate yield of the desired diketo amide 155 (Table 17, entry 1-2). Second,
silica gel flash chromatography was not an efficient technique to purify amide 155. Proton NMR analysis
always showed the presence of unidentifiable impurities. Furthermore, we were unable to scale the
reaction even to 3.5 mmol. Attempting different reaction conditions, with or without catalyst, we
recovered methyl ester 153 (Table 17, entry 3-5). Employing excess base, 2.0 eq of the acylating
reagent, or heating the reaction mixture for long period of time did not make any difference (Table 17,
entry 7). Treatment of 153 with 10 eq of dimethylformamide (DMF) and 3 eq of the Et3N gave no
97

reaction.

o

Heating the reaction mixture at 100 C for two days gave the same result (Table 17, entry 8-

9).
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Table 17. Results of the acylation reaction of 153

Entry

mmol

154 (eq) / catalyst (eq)

Base (eq)

Conditions

1

0.7

1.2 / no catalyst

TEA (1.2)

0 C to r.t, 24 h

2

0.7

1.2 / DMAP (1.1)

TEA (1.2)

0 C to r.t, 24 h

3

3.5

1.2 / no catalyst

TEA (1.2)

0 C to r.t, 24 h

4

3.5

1.5 / no catalyst

TEA (1.2)

0 C to 70 C, 36
h

5

3.5

1.2 / DMAP (1.1)

TEA or
DIPEA (1.2)

0 C to 70 C, 36
h

6

0.7

1.2 / no catalyst

DIPEA (1.2)

0 C to 70 C, 36
h

7

3.5

2.0 / no catalyst

TEA or
DIPEA (4.0)

0 C to 70 C, 72
h

8

0.7

1.0 / DMF (10.0)

TEA (3.0)

0 C to r.t,

1.0 / DMF (10.0)

TEA (3.0)

Results

o

155 (32 %), 153 (9 %)

o

155 (35 %), 153 (12 %)

o

o

153 (40 %)

o

o

153 (52 %)

o

o

153 recovered

o

o

155 (< 5 %), 153 (52 %)

o

153 recovered

o

153 recovered

72 h
o

9

0.7

100 C, 48 h

155 (< 1%), 153
recovered

Looking forward to get better yield of the desired diketo amide 155, we applied another typical process to
form amide bonds, which is from the coupling of carboxylic acids and amines in presence of base and
activating reagents, such as dicyclohexylcarbodiimide (DCC) and hydroxyl benzotriazole (HOBt).

6,26,98

Oxopentanoic acid 157 was prepared from the commercially available oxopentanoic ester 156. Basic
hydrolysis of 156 gave 82 % of the acid (Scheme 65, inset).
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Unfortunately all the efforts to reach the desired oxoamide derivative 155 using this coupling protocol
resulted in the formation of byproducts and the recovery of some of the starting amine 153 (Table 18, 15).

Table 18. Results of the acylation reaction attempts of amine 153 using activating reagents
Entry

1

2

3

4

157 (eq) / DCC (eq) /
OHBt (eq)

mmol

DIPEA (eq)

Conditions

0.7

2.0

0 C to r.t, 24 h

0.7

3.0

0 C to r.t, 24 h

0.7

2.0

60 C, 48 h

0.35

2.0

0 C to r.t, 72 h

0.7

6.0

r.t to 60 C, 48 h

1.0 / 1.3 / 1.0

1.5 / 1.5 / 1.5

1.0 / 1.3 / 1.0

1.5 / 1.5 / 1.5

Results

o

160 + 162 + 163 +
153 + complex
mixture

o

160 + 162 + 163 +
153 + complex
mixture

o

160 + 162 + 163 +
153 + complex
mixture

o

160 + 162 + 163 +
153 + complex
mixture

o

5

3.0 / 3.0 / 3.0

160 + 162 + 163 +
153 + complex
mixture
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Although thin layer chromatography (TLC) of the crude reaction mixture showed many different spots, we
were able to separate the more prominent spots by silica gel column chromatography. As a result, we
1

obtained three fractions, and according with the H-NMR data the first one corresponded to the mixture of
dicyclohexylurea (DCU) 162 and N-acylurea 160. The second fraction was a mixture of some DCU, Nacylurea and OBt ester 163 (Scheme 66) while the third fraction belongs to the not clean starting amine
153. It is important to point out that the exactly same behavior of this acylation methodology was
o

observed by varying the conditions and heating reaction at 60 C for long periods of time (Table 18, entry
1-5).
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We also tried this method to couple amine 153 with the more electrophilic dioxopentanoic acid 165. This
acylating reagent was prepared from oxopentanoic ester 156, which was oxidated with NaNO2 to afford
the oxime 164. Subsequent deoximation employing Zn/AcOH, followed by basic hydrolysis afforded 85 %
yield of the desired dioxo acid 165 (Scheme 67, inset). After attempting different several reaction
conditions the desired dioxyamide 166 was not observed. Instead DCU and the corresponding N1

acylurea byproducts were observed in the H-NMR spectrum of the crude mixture.

2. Efforts to build the Vicinal Tricarbonyl Region via Aminolysis
It has been demonstrated that the heating of a mixture of an amine with carboxylic acids or esters,
respectively, is another method for the preparation of amides.

99

For example, Cressman synthesized β-

keto amide derivative 169 by the pyrolysis reaction of β-keto ester 168 and ethylpipecolinate 167
100

(Scheme 68, inset).

Thus, we were expected that aminolysis of either oxopentanoic ester 156 or 156a

with amino ester 153 would furnish the corresponding wanted oxoamide 155 (Scheme 68). However, the
amino ester was inert to the aminolysis process. Heating the reaction mixture in presence of high boiling
point solvents for 72 h returned only starting amine 153.
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o

In addition, setting the pyrolysis of 153 with oxopentanoic acid chloride 154 for 3 days at 120 C or with
o

propionyl dioxinone 170 in a sealed tube for 7 days at 160 C did not produce the desired 155 amide. In
both cases 153 was completely recovered (Scheme 69).
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Due to the close similarities between Crossman’s pyrolysis and ours, it is important to mention that most
of the aminolysis experiments described above were repeated several times, and in our hands the
formation of the product was never observed; instead we always recovered the starting amine 153.
These unsuccessful results might be attributed to the lack of nucleophilicity of 153 which is a methyl
pipecolinate hydrochloride salt derivative.

In order to make free amino ester acid 171, the hydrochloric amino ester salt 153 was dissolved in water
and passed through a column of amberlite i.r.-120.
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The residue obtained after rotatory evaporation of

the water was crystallized from methanol-ether (90:10) to give 70 % of 171. Pyrolysis of 171 with
o

oxopentanoic ester 156a for 32 h at 120 C did not produce the expected oxoamide 155, and only the
starting amino ester 171 was recovered (Scheme 70).

Although the acylation reaction of 153 generated the desired oxopiperidine derivative 155 in modest yield
(35 %) (cf. Table 18, entry 2), we decided to stay with it and continue with the synthesis of fragment II, the
pinacolborane complex 176, and therefore try the Suzuki coupling strategy to construct the desired
fragment of the natural product.
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3. Attempts to Synthesize Borane-pentamide 176 via Iridium-Catalyzed Hydroboration
The addition of H-B reagents to alkenes and alkynes in the absence of catalysis requires high
temperatures and long reaction times. On the other hand, catalyzed hydroboration can be carried out at
room temperature and can also enhance the chemo-, regio- and stereoselectivities of the process.

Miyaura et al.

103

102

has demonstrated that [Ir(cod)Cl]2/dppm and [Ir(cod)Cl]2/dppe complexes are

extraordinary catalysts for hydroboration of terminal and internal olefins containing an aliphatic or
aromatic substituent on the vinylic carbon with pinacolborane. This iridium-catalyzed hydroboration with
pinacolborane methodology was applied to different alkenyl amides to prepare the corresponding boronic
104

esters in good yields (Scheme 71).

Thus, we applied this hydroboration protocol to our substrate, the pentenamide 35a. The reaction was
carried out at room temperature employing 1.5 eq of pinacolborane, 0.1 eq of [Ir(cod)Cl] 2 and 0.2 eq of
dppm as a ligand (Scheme 72). Unfortunately, this process did not work for our amide substrate. All the
efforts to get the desired alkylborane 176 ended in the recovering of ~ 12 % of pinacolborane, ~ 32 % of
impure starting material and some decomposition products.
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J. Future Work
Due to the unsatisfactory results making fragments I and II, we propose other alternatives to construct the
C10-C21 unit of the natural product. First, there are multiple reports that show the ring-opening Weinreb
96,104, 105

amide formation of lactones that are structurally similar to our lactone 137.

Thus, we would like to

explore more this reaction and we also believe that it is possible to generate a reactive amide 148.
Second, we plan to set the C17-C21 hexadiene unit by nucleophilic addition of the lithium anion derived
from iodide 177 to Weinreb amide 148. Iodide 177 can be obtained in 4 steps from 1,5-pentanediol.
Following standard protocols we expected to generate the iodo undecadiene 136. Third, apply Evan’s
alkylation reaction to 136 to install the desired C11 stereorelationship (Scheme 73).
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III. EXPERIMENTAL SECTION
General Information
All reactions were carried out under a nitrogen atmosphere using standard Schlenk techniques. All
commercially available compounds were purchased from Alfa Aesar Organics, Acros Organics and
Oakwood Products and used as received unless otherwise specified. Diethyl ether (Et2O),
tetrahydrofurane (THF) and dichloromethane (DCM) were purified over alumina using Solv-Tek ST-002
solvent purification system. Toluene and benzene were purified under CaH2, and methanol was drying
using molecular sieves (3 Å). Compound purification was performed by flash chromatography with the
indicated solvents using 230x400 mesh, 60 Å porosity purchased from Sorbent Technologies, and by
recrystallization from indicated solvents. Melting points were acquired on Fisher-Johns 352 melting point
1

apparatus. All H and

13

C NMR spectra were obtained on a 400 MHz Bruker Avance spectrometer. X-ray

crystallography was carried out on a Bruker SMART X2S.

Extractive work-up is defined as extraction of the reaction mixture and the indicated aqueous solution
three times with Et2O or DCM and washing of the combined organic extracts with saturated NaCl solution.
The extracts are drying over anhydrous MgSO4 and concentrated in vacuo.
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Trimethylsilylamine 72

To a hexane solution of (S)-α-methylbenzylamine (33) (6.0 g, 50.0 mmol) was added
TEA (10.5 mL, 74.3 mmol). The reaction mixture was heated under reflux for 15 min and then freshly
distillated TMSCl (9.50 mL, 74.3 mmol) was added. After the mixture cooled to rt, stirring was continued
for 24 h. The precipitated triethylammonium chloride was removed by filtration and washed with hexane.
o

The solution was concentrated in vacuo. The residual colorless liquid was distilled in vacuo (bp.75 C,
1

0.9 mm Hg) to give 6.7 g (28.9 mmol, 70 %) of silylamine 72. H NMR (400 MHz, CDCl3) δ 0.41 (s, 9H),
0.83 (br. s, 1H), 1.39 (d, J = 6.6 Hz, 3H), 4.06 (q, J = 6.6 Hz, 1H), 7.29-7.32 (m, 5H).

Silyloxyamine 73

To a solution of (S)-α-methylbenzylamine 33 (1.5 g, 12.3 mmol) and
o

TMSOTf (2.24 mL, 12.3 mmol) in ether (30 mL) at 0 C was added DBU (1.84 mL, 12.3 mmol) dropwise.
After stirring for 1 h, a solution of acrolein (1.38 mL, 12.3 mmol) and TIPSOTf (3.33 mL, 12.3 mmol) in
o

ether (15 mL) was added and stirred for 1 h at 0 C. The mixture was allowed to warm to rt and stirred for
6 h. The crude product was isolated by extractive work-up with Et2O and purified by flash
chromatography with 15/85 ethyl acetate/hexane to give the silyloxyamine 73 as clear yellow oil (1.82 g,
1

44 %). H NMR (400 MHz, CDCl3) δ 1.09 (s, 21H), 1.35 (dd, J= 6.55, J= 2.98, 3H), 3.81-3.88 (m, 1H),
13

5.08-5.18 (m, 1H), 6.39 (d, J= 14.87 Hz, 1H), 7.28-7.34 (m, 5H); C NMR (100 MHz, CDCl3) δ 12.00,
17.75, 24.29, 44.84, 56.98, 108.67, 126.66, 128.42, 143.01, 145.45.
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Silyloxyallyl-propanamide 34

o

To a solution of amine 73 (6.0 g, 17.96 mmol) in DCM (30 mL) at 0 C
was added the Et3N (3.00 mL, 21.55 mmol) and propanoyl chloride (1.87 mL, 21.55 mmol) dropwise. The
mixture was allowed to warm to rt and stirred for 30 min. The crude product was isolated by extractive
work-up with DCM, and purified by flash chromatography with 2/98 ethyl acetate/hexane to give
1

propanamide 34 as colorless oil (6.7 g, 96 %). H NMR (400 MHz, CDCl3) δ 1.19-1.04 (m, 24H), 1.53 (d, J
= 7.03 Hz, 3H), 2.41 (q, J = 4.78 Hz, 2H), 3.46 (dd, J = 6.65, J = 16.73, 1H), 4.76 (m, 1H), 6.06 (dd, J =
13

13.99, 1H), 6.27 (d, J =11.92, 1H); C NMR (100 MHz, CDCl3) δ 9.52, 11.92, 16.89, 17.66, 26.99, 41.63,
51.00, 107.73, 122.20, 127.54, 128.36, 128.61, 141.30, 143.46, 174.20. Elemental Analysis: calcd for
C23H39NO2Si: C 70.90, H 10.09, N 3.59, found C 70.15, H 9.92, N 3.53

β-silyloxy amide 35a

Amide 34 (9.6 g, 24.6 mmol) was treated with LHMDS (54.6 mL, 0.9 M
o

solution in hexane, 49.12 mmol) in toluene (200 mL) at -78 C. After stirring 30 min the reaction mixture
o

was allowed to warm to rt, sealed in a pressure tube and heated at 120 C for 6 h. The crude product was
isolated by extractive work-up with Et2O to give 82 % of the diastereomeric amide mixture 35. The major
diastereomer 35a was separated by flash column chromatography with 2/98 ethyl acetate/hexane as a
o

1

white solid (7.80 g, 7.7:1.0 dr, mp. 87 C). H NMR (400 MHz, CDCl3) δ 1.11-1.05 (m, 24H), 1.47 (d, J =
13

6.90, 3H), 2.63 (m, 1H), 4.27 (m, 1H), 5.13 (m, 1H), 5.23 (m, 2H), 5.86 (m, 1H), 7.26-7.04 (m, 5H); C
NMR (100 MHz, CDCl3) δ 12.16, 12.91, 18.02, 21.83, 45.95, 48.45, 77.05, 117.20, 126.26, 127.10,
128.50, 136.20, 171.80. Elemental Analysis: calcd for C23H39NO2Si: C 70.90, H 10.09, N 3.59, found C
70.92, H 10.15, N 3.59
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Hydroxy pentenamide 75

β-Silyloxy amide 35a (1.8 g, 4.61 mmol) was treated with 36 mL of a 5:95
solution of hydrofluoric acid and acetonitrile. The reaction mixture was stirred for 30 min, and then 2 mL
of 1M HCl was added. The crude product was isolated by extractive work-up with Et2O. The hydroxy
o

1

pentenamide 75 was formed as a white solid. (0.97 g, 91 %, mp. 144 C ). H NMR (400 MHz, CDCl3) δ
1.14 (d, J = 6.44 Hz, 3H),1.49 (d, J = 6.48 Hz, 3H), 2.43 (m, 1H), 3.61 (br. s, OH), 4.43 (t, J = 6.88 Hz,
1H), 5.14 (t, J = 6.88 Hz, 1H), 5.21 (app. d, J = 10.44 Hz, 1H), 5.32 (app. d, J = 17.20 Hz, 1H), 5.82 (m,
1H), 7.29-7.33 (m, 5H),

13

C NMR (100 MHz, CDCl3) δ 11.59, 21.97, 44.70, 48.65, 73.38, 116.42, 126.01,

127.35, 128.69, 137.25, 174.78. Elemental Analysis: calcd for C14H19NO2: C 72.07, H 8.21, N 6.00, found
C 71.56, H 8.21, N 5.97

(+/-) - Butenoic acid 93

n-Butyllithium (35.9 mL, 2.87 M in hexane, 104.88 mmol) was added to a solution of
o

diisopropylamine (15 mL, 109.87 mmol) in THF at -78 C. A pale yellow solution was obtained after the
stirred the mixture for 20 min under N2 atmosphere. Then, a solution of tiglic acid (5.0 g, 49.9 mmol) in 30
o

mL of THF was added over a period of 30 min. The bath temperature was keeping between -40 C to –
o

20 C during the addition. The resulting yellow mixture was stirred at rt for 1h and then poured into stirred
ice-cold solution of 3 M HCl (120 mL). The organic layer was separated, and the aqueous layer was
saturated with solid NaCl and extracted with ethyl acetate. The yellow crude oil was purified by reduced
o

1

pressure distillation to generate the pure acid as colorless oil (3.8 g, 80 %, bp. 85 C). H NMR (400
MHz, CDCl3) δ 1.32 (d, J = 7.08 Hz, 3H), 3.19 (q, J = 7.16 Hz, 1H), 5.17 (app. tdt, J = 1.25, 1.13, 11.29
Hz, 2H), 5.94 (tt, J = 7.2, 10.08 Hz, 1H), 11.67 (br. s, OH),

13

C NMR (100 MHz, CDCl3) δ 16.45, 43.47,

116.47, 136.40, 181.14.
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(+/-) – Butenoyl chloride 92

The butenoic acid 93 (2.0 g, 19.98 mmol) was placed in a dry flask under N 2 atmosphere
o

and cooled at 0 C. Then, freshly distilled oxalyl chloride (1.9 mL, 23.97 mmol) was added and the
mixture was stirred overnight, allowing the ice bath to warm up to r.t. The acid chloride 92 was formed as
1

pale yellow oil (1.7 g, 72 %). H NMR (400 MHz, CDCl3) δ 1.39 (d, J = 7.20 Hz, 3H), 3.56 (q, J = 7.20 Hz,
1H), 5.31 (m, 2H), 5.91 (tt, J = 7.2, 10.0 Hz, 1H),

13

C NMR (100 MHz, CDCl3) δ 18.45, 48.47, 115.57,

137.40, 173.04.

Allyl ester 36

To a solution of butenoic acid 93 (45 mg, 0.45 mmol) in DCM (10
o

mL) at 0 C was added DMAP (27.5 mg, 0.22 mmol), the hydroxyl pentenamide 75 (0.11 mg, 0.49 mmol)
and DCC (0.10 g, 0.49 mmol). The mixture was allowed to warm to rt and stirred for 72 h. The resulting
mixture was filtered and washed with 1M HCl. The crude product was isolated by extractive work-up with
Et2O. The crude was purified by flash chromatography with 10/90 ethyl acetate/hexane to give allyl ester
1

36 as a white solid (80 mg, 57 %). H NMR (400 MHz, CDCl3) δ 1.17 (d, J = 7.0 Hz, 3H), 1.28 (d, J = 7.0
Hz, 3H), 1.49 (d, J = 6.88 Hz, 3H), 2.51 (quint, J = 6.96, 13.30 Hz, 1H), 3.16 (quint, J = 7.18, 14.12 Hz,
1H), 5.08 (m, 1H), 5.15 (m, 1H), 5.27 (m, 2H), 5.38 (m, 1H), 5.83 (m, 1H), 5.87 (m, 1H), 5.91 (m, 1H),
7.31-7.37 (m, 5H),

13

C NMR (100 MHz, CDCl3) δ 13.24, 16.53, 21.52, 43.93, 44.87, 48.64, 76.12, 116.47,

118.66, 126.21, 128.70, 128.61, 133.12, 136.87, 142.97, 171.19, 172.92.
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δ-Lactone 37

In a pressure vessel was mixed allyl ester 36 (0.1 g, 0.3174 mmol),
diallyl malonate 107, and 12 % mol of Grubbs’ II in toluene (100 mL). The reaction mixture was sealed
o

and heated for 2 h at 80 C, then cooled to room temperature. The solvent was removed and the residue
was purified by flash chromatography with 10/90 ethyl acetate/hexane to yield the cyclized product 37 (68
1

mg, 73 %). H NMR (400 MHz, CDCl3) δ 1.22 (d, J = 6.80 Hz, 3H), 1.24 (m, 1H), 1.35 (d, J = 7.20 Hz,
3H), 1.42 (d, J = 6.80 Hz, 3H), 2.61 (m, 1H), 5.07 (m, 1H), 5.79 (m, 1H), 5.87 (m, 1H), 6.44 (m, 1H), 7.10
13

(m, 5H); C NMR (100 MHz, CDCl3) δ 12.85, 17.16, 21.98, 29.68, 45.32, 48.90, 80.19, 124.14, 126.07,
127.31, 128.65, 129.76, 143.01, 171.15, 172.26.

Hydroxy lactam 132

The β-silyloxy amide 35a (0.26 g, 0.67 mmol) was taken up in 8 mL of
DCM:MeOH (1:1) followed by the addition of pyridine (0.53 g, 6.67 mmol) and SUDAN III (indicator, 1 mg)
o

at rt. The solution was cooled to -78 C and exposed to a stream O3 until a light yellow color persisted.
The reaction mixture was stirred until the SM was totally consumed based on TLC analysis. The flask
was flushed with N2, and Me2S (2.07 g, 33.36 mmol) was slowly added and allowed to warm up to rt over
a 4 h period. After stirring for 1 h at rt, Et2O (20 mL) was added and the mixture extracted with a
saturated solution of CuSO4 and then brine. The organic layer was concentrated and the crude product
was purified by silica gel column chromatography (10/90 EtOAc/hexane). The lactam 132 was isolated
1

as light yellow oil (0.18 g, 72 %). H NMR (400 MHz, CDCl3) δ 0.97 (m, 18H), 1.24 (m, 3H), 1.33 (d, J =

84

7.60 Hz, 3H), 1.65 (d, J = 7.20 Hz, 3H), 2.37 (q, J = 7.41 Hz, 1H), 3.86 (app. s, 1H), 4.74 (app. s, 1H),
13

5.39 (q, J = 7.08 Hz, 1H), 7.29–7.35 (m, 5H); C NMR (100 MHz, CD6CO) δ 11.70, 14.70, 17.26, 18.27,
46.65, 49.10, 79.48, 87.52, 126.98, 128.11, 141.08, 175.52.

Hydroxyamide 138

To a stirred solution of cyclohexene (6.56 g, 79.97 mmol) in ether
o

(40 mL) at 0 C was added BH3.SMe2 (4.0 mL, 10 M in THF, 45.01 mmol) through an addition funnel. The
o

mixture was stirred for 3 h at 0 C, during which white crystals precipitated. A THF solution of the βsilyloxy amide 35a (4.0 g, 10.26 mmol) was added to the mixture and stirred until a clear solution was
observed. A 3 M solution of NaOH (10.24 mL, 30.79 mmol) was added slowly, followed by the addition of
MeOH (4 mL) and the slow addition of H2O2 (1.04 mL, 35 % wt in water, 12.32 mmol). The reaction
o

mixture was stirred at rt for 3 h and then heated under reflux for 1 h at 40 C. Extractive work-up with
Et2O yielded a white oil which was purified by silica gel flash chromatography using MeOH/DCM (5 / 95).
1

The purified hydroxyamide 138 was a colorless viscous oil (3.01 g, 72 %). H NMR (400 MHz, CDCl3) δ
1.04 (m, 18H), 1.07 (m, 3H), 1.12 (d, J = 7.20 Hz, 3H), 1.45 (d, J = 6.80 Hz, 3H), 1.83 (m, 2H), 2.64 (m,
13

1H), 3.79 (m, 2H), 4.12 (m, 1H), 5.11 (quint, J = 7.2 Hz, 1H), 7.29–7.32 (m, 5H), C NMR (100 MHz,
CD6CO) δ 12.64, 13.26, 18.14, 21.66, 35.97, 45.92, 48.68, 59.31, 72.97, 126.27, 127.22, 128.54, 143.36,
172.89. Elemental Analysis: calcd for C23H41NO3Si: C 67.76, H 10.14, N 3.44, found C 66.99, H 10.07, N
3.22
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Silyloxypyranone 137

A mixture of hydroxyamide 138 (2.50 g, 6.13 mmol) and p-TsOH (1.28 g, 6.74 mmol) in
benzene was heated under reflux for 15 min. After concentration in vacuo, silica gel column
chromatography (EtOAc/hexane 5/95) of the residue provided product 137 as dense colorless oil (0.84 g,
1

48 %) and recovered 138 (0.29 g, 32 %). H NMR (400 MHz, CDCl3) δ 1.06 (m, 18H), 1.08 (m, 3H), 1.34
(d, J = 7.40 Hz, 3H), 1.84 (m, 1H), 2.13 (m, 1H), 2.65 (m, 1H), 4.01 (dd, J = 4.89, 8.53, 1H), 4.29 (dt, J =
13

4.71, 4.71, 11.17, 1H), 4.59 (td, J = 3.70, 10.73, 10.92 Hz, 1H), 7.29–7.32 (m, 5H), C NMR (100 MHz,
CD6CO) δ 12.29, 15.72, 18.00, 29.68, 44.93, 64.82, 70.19, 173.89. Elemental Analysis: calcd for
C15H30O3Si: C 62.89, H 10.59, found C 62.93, H 10.54

Pyranol 146

Allyl magnesium bromide (1M in Et2O, 41.88 mL, 40 mmol) was cooled to –
o

10 C and propargyl chloride (9.3 M in toluene, 2.25 mL, 20 mmol) was added dropwise. The solution
o

was stirred for 5 h at rt, during which time it became heterogeneous. The mixture was cooled to 0 C and
silyloxypyranone 137 (150 mg, 0.52 mmol) was added dropwise. The mixture was allowed to stir at rt for
14 h and the crude product was isolated by extractive work-up with Et2O. The concentrated residue was
1

partially purified by silica gel column chromatography using (EtOAc/hexanes, 10/90), (51 mg, 27 %). H
NMR (400 MHz, CDCl3) δ 1.05 (m, 18H), 1.08 (m, 3H), 1.25 (d, J = 7.10 Hz, 3H), 1.54 (m, 1H), 1.71 (m,
1H), 1.99 (m, 1H), 2.30 (m, 2H), 2.32 (m, 2H), 3.73 (m, 1H), 4.03 (m, 1H), 4.29 (m, 1H), 5.04 (m, 2H),
5.85 (m, 1H),

13

C NMR (100 MHz, CD6CO) δ 1.00, 12.18, 13.36, 17.98, 29.69, 32.53, 44.57, 57.07, 72.10,

79.71, 84.47, 95.28, 115.67, 136.78. δ 1.14 (t, J = 7.20, 3H), 1.84 (s, N-OH), 2.83 (q, J = 7.20, 2H), 3.91
(s, 3H),

13

C NMR (400 MHz, CD6CO) δ 12.94, 31.54, 51.26, 137.74, 144.63, 161.67.
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Oxopentanoyl amide 161

A mixture of piperidine ester 153 (100 mg, 0.70 mmol), oxopentanoyl chloride
154 (112 mg, 0.84 mmol) and NEt3 (0.12 mL, 0.84 mmol) in DCM (15 mL) was heated under reflux for 24
h. The concentrated residue was purified by silica gel column chromatography (EtOAc/hexanes, 25/75)
1

to give a colorless oil of amide 155 (54 mg, 32 % yield). H NMR (400 MHz, CDCl3) δ 1.07 (t, J = 7.22
Hz, 3H), 1.30 (m, 1H), 1.46 (ddd, J = 3.83, 7.40, 11.29 Hz, 1H), 1.61 (m, 1H), 1.65 (m, 1H), 1.72 (m, 1H),
2.37 (m, 1H), 2.60 (qd, J = 2.26, 7.28, 7.28, 7.28 Hz, 2H), 3.22 (td, J = 2.89, 13.05, 13.05 Hz, 2H), 3.58
(s, 2H), 3.75 (s, 3H), 5.36 (d, J = 5.52 Hz, 1H),

13

C NMR (100 MHz, CD6CO) δ 7.55, 20.77, 25.13, 27.11,

35.94, 44.30, 49.38, 52.05, 52.27, 166.20, 171.44, 205.08.
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